Overview

Efficacy and Safety of Nitazoxanide in Preventing Recurrence of Hepatic Encephalopathy

Status:
Recruiting
Trial end date:
2028-12-01
Target enrollment:
Participant gender:
Summary
Efficacy and Safety of Nitazoxanide in preventing recurrence of Hepatic Encephalopathy.
Phase:
Phase 3
Details
Lead Sponsor:
Tanta University
Treatments:
Nitazoxanide
Rifaximin